TIL
Companies
NASDAQ
Instil Bio Inc.
Health Care
$28.53
+$9.44 (+49.45%)
Price Chart
Overview
About TIL
Instil Bio Inc is a clinical-stage biopharmaceutical company focused on developing a cell therapy pipeline of autologous tumor infiltrating lymphocyte, or TIL, therapies for the treatment of patients with cancer. It is also engaged in developing a novel class of genetically engineered TIL therapies using its Co-Stimulatory Antigen Receptor, or CoStAR, platform. Its pipeline includes ITIL-306 which expresses a CoStAR molecule designed to recognize FRα, a tumor-associated antigen that is expressed on numerous solid tumors, including ovarian cancer, uterine cancer, NSCLC, and renal cancer.
Market Cap
$69.6M
Volume
2.2M
Avg. Volume
4.1M
P/E Ratio
-1.3595692
Dividend Yield
0.00%
Employees
192.0
Company Information
Risk & Correlation Analysis
Market Correlation
1.17
Moderate Correlation
Volatility
High (1.00)
Relative to market
Macro Factor Sensitivities
Interest Rates
Low Sensitivity
Inflation
Medium Sensitivity
GDP Growth
Low Sensitivity
Liquidity
Medium Sensitivity
Commodity Prices
Low Sensitivity
Credit Quality
Medium Sensitivity
Portfolio Impact
Forecasts & Predictions
1-Month Target
$XXX.XX
+X.X% Potential
3-Month Target
$XXX.XX
+X.X% Potential
12-Month Target
$XXX.XX
+X.X% Potential
Technical Analysis
Based on technical indicators and chart patterns, TIL shows...
AI Sentiment Analysis
Market sentiment analysis indicates...
Key Statistics
Market Cap$69.6M
Volume2.2M
P/E Ratio-1.36
Dividend Yield0.00%
Important Dates
Next Dividend
Next Earnings
May 13, 2025Related Securities
Pricing info last updated June 19, 2025 (after market close)Other info last updated April 2, 2025